Antiviral Strategies

Page 5 of18 - nation doesn't quite succeed in stopping measurable viral activity, many researchers believe it may be wise to either change two of the drugs, or perhaps add a fourth drug. It makes sense to try and fully suppress viral replication if this can be done with a reasonable quality of life. When this goal cannot be achieved, people should realize they can still benefit from therapy and that longer-term solutions may become apparent when additional therapies are available. Using a drug exactly as prescribed is critical to success. Using an inadequate dose, reducing the dose below the prescribed level, or failing to take the drug at regularly spaced intervals will increase the risk of developing viral resistance. If intolerance or side effects develop, it is often better to try to overcome the side effects than to immediately change the regimen. If side effects aren't manageable, it is better to temporarily stop the drug rather than reduce its dose. This runs counter to common clinical practice with the nucleoside analogue reverse transcriptase inhibitors or NARTIs (e.g. AZT, ddl, ddC, d4T and 3TC), in which physicians routinely lowered doses as a way of dealing with side effects. The fastest way to develop resistance to antiviral drugs is to use them at an inadequate or inconsistent dose level. If you need to take a "drug holiday," it is best to stop all antiviral therapies at the same time rather than just stopping one drug. There are a number of reasons that people may need to stop taking their medications, including side effects, drug interactions, pregnancy or their drug supply runs out. There are no studies that indicate how many days, weeks or months "vacation" from antiviral drugs is likely to increase drug resistance. However, it is clear that if a person needs to stop therapy for whatever reason, it is best to stop taking all drugs at the same time. In the presence of a partially effective antiviral regimen, the virus is able to reproduce, mutate and develop resistance to the remaining therapies. However, if all drugs are stopped simultaneously, there is no selective pressure for the virus to mutate. What Therapy Should I use? Ideally, the best drug combination to use would be the one that is most successful in reducing viral load below the limit of detection for the longest time, while preserving quality of life. In the real world, what is best for the individual is sometimes different from what works best in a clinical trial. Some drugs and combinations are clearly more potent than others. In some instances, the differences between various combinations are not clearly defined, largely because comparative studies have not been done. Drug manufacturers try to avoid conducting studies that make direct comparisons. While this may be good for them, it often leaves the patient in the dark. Still, a reasonable amount of data are avail Antiviral Strategies Discussion Paper -TABLE: Federal Recommendations on Combination Therapy Choose one drug from Column A (highly active protease inhibitors) and one combination from Column B (NARTIs) COLUMN A Indinavir Ritonavir Nelfinavir COLUMN B AZT + ddi d4t+ ddl AZT + ddC AZT + 3TC d4T + 3TC Alternative Combinations The following combinations are recommended as alternative combination regimens. Nevirapine + 2 NARTIs (one combination from column B above) Saquinavir+ 2 NARTIs (one combination from column B above) Not generally recommended: 2 NARTIs (column B above) The following combinations are not recommended: d4T + AZT ddC + ddi ddC + d4T ddC + 3TC able which allows us to conclude that some drugs are "highly active" antivirals and some are less active. In general, the most effective combination therapy regimens contain at least two "highly active" antivirals, usually added to a third drug of similar or lesser potency but which works in a different way. Within the realm of combinations with adequate overall potency, other factors become important in selecting a therapy regimen. Quality of Life Issues Tolerance can be as important as the potency of a drug. If you can't take a drug consistently as prescribed, its potency is irrelevant. Lack of adherence to the protocol will quickly contribute to the development of drug-resistant mutations of HIV. When choosing a combination, consider the daily pills count (antiretrovirals, drugs for opportunistic infections and everything else), when they will be taken, whether they can be taken with other medications and whether they can be taken with food. It is easiest to combine drugs that require similar conditions for their use (with food, without food etc.). Otherwise, one's life becomes dominated by drug schedules. Also it is best to avoid mix Son Francisco Project Inform - 1965 Market St., Suite 220, San Francisco, CA 94103

/ 20

Actions

file_download Download Options Download this page PDF - Pages 1- Image - Page 5 Plain Text - Page 5

About this Item

Title
Antiviral Strategies
Author
Project Inform (San Francisco, Calif.)
Canvas
Page 5
Publication
Project Inform
1997-08
Subject terms
newsletters
Item type:
newsletters

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0291.009
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.009/5

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0291.009

Cite this Item

Full citation
"Antiviral Strategies." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0291.009. University of Michigan Library Digital Collections. Accessed May 10, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.